Tuberculosis cases surged to 10,388 in 2024 while our government prioritized COVID mandates over a resurgent disease that kills more untreated patients and now resists the very antibiotics designed to stop it.
Story Snapshot
- Tuberculosis cases climbed to 10,388 in 2024 after COVID-19 disruptions caused missed diagnoses and treatment delays in high-risk populations.
- The disease disproportionately affects immigrants, ethnic minorities, and prisoners—groups neglected by public health policies focused elsewhere.
- Multidrug-resistant TB strains now threaten control efforts, with no effective adult vaccine available beyond a century-old option.
- Roughly 77,000 cases across the Americas went undiagnosed in 2024, fueling continued transmission and resistance.
COVID-19 Disruptions Fueled TB Resurgence
The COVID-19 pandemic derailed tuberculosis control from 2020 through 2023, causing diagnostic and treatment delays that allowed latent TB infections to progress into active disease. US cases reached 10,388 in 2024, reversing years of stabilization efforts.
Across the Americas, approximately 350,000 people fell ill with TB that year, yet 77,000 cases remained undiagnosed. This breakdown in surveillance mirrors the federal government’s tendency to chase headline crises while neglecting chronic threats that disproportionately harm vulnerable communities, including immigrants and ethnic minorities already burdened by inadequate healthcare access.
'White plague' is on the rise in the US – it's deadlier than Covid and becoming antibiotic resistant https://t.co/RbrjT2kbyJ pic.twitter.com/nD0UC5lwm8
— New York Post (@nypost) March 25, 2026
High-Risk Populations Bear Disproportionate Burden
Tuberculosis concentrates in congregate settings like prisons, where transmission rates spike due to overcrowding and poor ventilation. Immigrants, ethnic minorities, low-income individuals, and those with HIV coinfection face elevated risk, yet screening for latent TB infection remains inconsistent.
Dr. Walter of the University of Utah notes that incarceration environments amplify transmission, while air pollution may increase susceptibility. These disparities reflect systemic failures to address social determinants of health—poverty, stigma, and limited access—that perpetuate TB as a “disease of neglect.”
Meanwhile, resources poured into pandemic responses left TB control underfunded and understaffed.
Antibiotic Resistance Threatens Control Efforts
Multidrug-resistant TB strains now complicate treatment, with resistance emerging to fluoroquinolones and other first-line antibiotics. Standard TB therapy requires four to six months of multi-drug regimens, a burden that fosters noncompliance and further resistance.
Dr. Carey emphasizes the urgent need for new vaccines and diagnostics, yet development lags behind demand. The only available vaccine, BCG, offers minimal protection for adults.
This crisis exposes the cost of government inertia: decades of under-investment in TB research have left us vulnerable to a pathogen that once devastated the US in the 19th and early 20th centuries, earning the moniker “white plague” for its pallor-inducing effects.
Government Priorities Misaligned with Threat
Federal agencies like the CDC and PAHO advocate for primary care integration and expanded screening, but funding shortfalls undermine implementation. In 2024, the Americas recorded 30,000 TB deaths, with 29% linked to HIV coinfection. NYC saw an 11% case decline in 2025, yet rates remain elevated nationally.
Experts call for evidence-based strategies targeting latent infection and transmission mapping, but policymakers prioritize short-term political wins over long-term health security. This mirrors the broader frustration with government overreach in areas that erode liberty while failing to protect citizens from preventable disease.
TB’s resurgence underscores the danger of misallocated resources and neglect of foundational public health infrastructure.
NEWS🚨: 'White plague' is on the rise in the US – it's deadlier than Covid and becoming antibiotic resistant, says NYP pic.twitter.com/hHoZ4EHqZP
— All day Astronomy (@forallcurious) March 25, 2026
As World TB Day 2026 spotlights these challenges, Americans rightly question why a treatable disease resurges while bureaucracies expand.
The answer lies in a system that rewards crisis management over prevention, leaving high-risk communities to bear the consequences of policy failures rooted in fiscal mismanagement and globalist agendas that prioritize optics over outcomes.
Sources:
Tuberculosis Resurgence in the United States: Post-COVID-19 Challenges
World Tuberculosis Day: What You Should Know 2026
World Tuberculosis Day 2026: Primary Health Care Key to More Accessible, People-Centered TB Services
NYC Health Department Marks World Tuberculosis Day 2026
